Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.640
+0.040 (1.11%)
At close: Dec 19, 2025, 4:00 PM EST
3.680
+0.040 (1.10%)
After-hours: Dec 19, 2025, 7:58 PM EST

Prime Medicine Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
6443738171,609--
Upgrade
Market Cap Growth
61.36%-54.41%-49.22%---
Upgrade
Enterprise Value
5492386691,890--
Upgrade
Last Close Price
3.642.928.8618.58--
Upgrade
PS Ratio
83.53124.90----
Upgrade
PB Ratio
3.982.436.145.09--
Upgrade
P/TBV Ratio
3.982.436.145.09--
Upgrade
EV/Sales Ratio
91.9079.89----
Upgrade
Debt / Equity Ratio
0.730.270.100.090.040.52
Upgrade
Asset Turnover
0.020.01---0.16
Upgrade
Quick Ratio
6.095.022.1611.004.652.74
Upgrade
Current Ratio
6.615.582.5311.104.672.75
Upgrade
Return on Equity (ROE)
-112.34%-136.88%-88.19%-43.83%-121.13%-19.56%
Upgrade
Return on Assets (ROA)
-35.52%-51.51%-43.15%-22.00%-29.61%-1.84%
Upgrade
Return on Capital (ROIC)
-49.92%-74.30%-48.63%-24.48%-35.09%-2.22%
Upgrade
Return on Capital Employed (ROCE)
-58.30%-78.00%-139.20%-34.90%-34.60%-2.60%
Upgrade
Earnings Yield
-30.62%-52.58%-24.25%-7.57%--
Upgrade
FCF Yield
-17.86%-34.94%-21.31%-9.19%--
Upgrade
Buyback Yield / Dilution
-25.86%-30.37%-168.41%-161.23%-391.47%-77.53%
Upgrade
Updated Nov 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q